glp 1 psychiatry Glucagon-like peptide-1 medicines in neurological and psychiatric disorders: Cell Reports Medicine GLP-1s Like Ozempic May Be

Treatment Decision-Making Treatment decision-making can be guided by the different mechanisms of action of AOMs to ascertain the suitability of the therapy for the individual patient

The median weight change among GLP-1 users was an 11.5% reduction, compared to a 1.9% reduction for metformin users

Not exhaustive, but highly practical

The study from Sekhar and colleagues presents findings suggesting that GlyNAC may provide a means to diminish cellular stress and improve strength, physical function, and cognition in aged adults

MPNST occurs most frequently in the head and neck or the upper extremities and only 1% of cases have been identified in the retroperitoneum (3)

For these individuals, the acute respiratory phase of the virus may have passed, but it has been replaced by a complex, multi-systemic condition that profoundly alters daily life